183 related articles for article (PubMed ID: 36173796)
1. Anesthetic Management of Gastrointestinal Carcinoid Tumors: A Case Report.
Wiederholt B; Gengler T; Bendure J
AANA J; 2022 Oct; 90(5):377-382. PubMed ID: 36173796
[TBL] [Abstract][Full Text] [Related]
2. Development of effective prophylaxis against intraoperative carcinoid crisis.
Woltering EA; Wright AE; Stevens MA; Wang YZ; Boudreaux JP; Mamikunian G; Riopelle JM; Kaye AD
J Clin Anesth; 2016 Aug; 32():189-93. PubMed ID: 27290972
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of Octreotide: Clinical Implications for Anesthesiologists and Associated Risks.
Borna RM; Jahr JS; Kmiecik S; Mancuso KF; Kaye AD
Anesthesiol Clin; 2017 Jun; 35(2):327-339. PubMed ID: 28526153
[TBL] [Abstract][Full Text] [Related]
4. Shifting Paradigms in the Pathophysiology and Treatment of Carcinoid Crisis.
Maxwell JE; Naraev B; Halperin DM; Choti MA; Halfdanarson TR
Ann Surg Oncol; 2022 May; 29(5):3072-3084. PubMed ID: 35165817
[TBL] [Abstract][Full Text] [Related]
5. Carcinoid crisis after biopsy of a bronchial carcinoid.
Karmy-Jones R; Vallières E
Ann Thorac Surg; 1993 Dec; 56(6):1403-5. PubMed ID: 8267450
[TBL] [Abstract][Full Text] [Related]
6. Treatment of liver metastases of carcinoid tumors.
Ahlman H; Westberg G; Wängberg B; Nilsson O; Tylén U; Scherstén T; Tisell LE
World J Surg; 1996 Feb; 20(2):196-202. PubMed ID: 8661817
[TBL] [Abstract][Full Text] [Related]
7. The presence of somatostatin receptors in malignant neuroendocrine tumor tissue predicts responsiveness to octreotide.
Kvols LK; Reubi JC; Horisberger U; Moertel CG; Rubin J; Charboneau JW
Yale J Biol Med; 1992; 65(5):505-18; discussion 531-6. PubMed ID: 1364090
[TBL] [Abstract][Full Text] [Related]
8. LANREOTIDE THERAPY IN CARCINOID SYNDROME: PROSPECTIVE ANALYSIS OF PATIENT-REPORTED SYMPTOMS IN PATIENTS RESPONSIVE TO PRIOR OCTREOTIDE THERAPY AND PATIENTS NAÏVE TO SOMATOSTATIN ANALOGUE THERAPY IN THE ELECT PHASE 3 STUDY.
Fisher GA; Wolin EM; Liyanage N; Lowenthal SP; Mirakhur B; Pommier RF; Shaheen M; Vinik AI;
Endocr Pract; 2018 Mar; 24(3):243-255. PubMed ID: 29547049
[TBL] [Abstract][Full Text] [Related]
9. Orthotopic liver transplantation for carcinoid tumour metastatic to the liver: anesthetic management.
Claure RE; Drover DD; Haddow GR; Esquivel CO; Angst MS
Can J Anaesth; 2000 Apr; 47(4):334-7. PubMed ID: 10764178
[TBL] [Abstract][Full Text] [Related]
10. [Surgical treatment of gastric, enteric, and pancreatic endocrine tumors Part 1. Treatment of primary endocrine tumors].
Kianmanesh R; O'toole D; Sauvanet A; Ruszniewski P; Belghiti J
J Chir (Paris); 2005; 142(3):132-49. PubMed ID: 16142076
[TBL] [Abstract][Full Text] [Related]
11. Diabetes Insipidus Induced by Combination of Short-acting Octreotide and Lanreotide for Recurrent Carcinoid Crisis of Neuroendocrine Tumour: A Case Report.
Guan GK; Rajoo S; Dusa NM; Yahya NHN; Bidin MBL
J ASEAN Fed Endocr Soc; 2021; 36(2):220-222. PubMed ID: 34966210
[TBL] [Abstract][Full Text] [Related]
12. An update of lanreotide acetate for treatment of adults with carcinoid syndrome.
Guadalupe E; Deshpande HA; Stein SM
Drugs Today (Barc); 2018 Aug; 54(8):457-465. PubMed ID: 30209440
[TBL] [Abstract][Full Text] [Related]
13. Nuclear localization of 111In after intravenous injection of [111In-DTPA-D-Phe1]-octreotide in patients with neuroendocrine tumors.
Janson ET; Westlin JE; Ohrvall U; Oberg K; Lukinius A
J Nucl Med; 2000 Sep; 41(9):1514-8. PubMed ID: 10994731
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin, anaesthesia, and the carcinoid syndrome. Peri-operative administration of a somatostatin analogue to suppress carcinoid tumour activity.
Roy RC; Carter RF; Wright PD
Anaesthesia; 1987 Jun; 42(6):627-32. PubMed ID: 2887127
[TBL] [Abstract][Full Text] [Related]
15. The prophylactic use of octreotide in a patient with ovarian carcinoid and valvular heart disease.
Watson JT; Badner NH; Ali MJ
Can J Anaesth; 1990 Oct; 37(7):798-800. PubMed ID: 2225298
[TBL] [Abstract][Full Text] [Related]
16. Use of somatostatin analog in management of carcinoid syndrome.
Vinik A; Moattari AR
Dig Dis Sci; 1989 Mar; 34(3 Suppl):14S-27S. PubMed ID: 2920654
[TBL] [Abstract][Full Text] [Related]
17. Anesthetic considerations and management of a patient with unsuspected carcinoid crisis during hepatic tumor resection.
Choi CK
Middle East J Anaesthesiol; 2014 Jun; 22(5):515-8. PubMed ID: 25137869
[TBL] [Abstract][Full Text] [Related]
18. Value of somatostatin receptor scintigraphy for preoperative localization of carcinoids.
Kisker O; Weinel RJ; Geks J; Zacara F; Joseph K; Rothmund M
World J Surg; 1996 Feb; 20(2):162-7. PubMed ID: 8661812
[TBL] [Abstract][Full Text] [Related]
19. Carcinoid syndrome.
Zambrzycki JK; Elliott CG
Nurse Anesth; 1993 Dec; 4(4):198-201. PubMed ID: 7907889
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Octreotide and Vasopressors as First-Line Treatment for Intraoperative Carcinoid Crisis.
McCully BH; Kozuma K; Pommier S; Pommier RF
Ann Surg Oncol; 2024 May; 31(5):2996-3002. PubMed ID: 38227166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
